News

  • April 29th, 2021 - Press notes

    The future of immunotherapy at the Optimizing Immunotherapy Congress

    The future of immunotherapy at the Optimizing Immunotherapy Congress The benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of this type of treatment for various types of tumours, as well as molecular diagnostics.

    more information

  • April 22nd - Press notes

    Anna Bigas, one of the Top 100 Women Leaders in Spain

    Anna Bigas, one of the Top 100 Women Leaders in Spain Dr. Anna Bigas, coordinator of the Stem cells and cancer Research Group of the Hospital del Mar Medical Research Institute (IMIM) and scientific director of the CIBER Oncology has been chosen one of the Top 100 Women Leaders in Spain.

    more information

  • 14 April 2021 - Press notes

    Precise moment of loss of consciousness during anaesthesia determined through magnetic resonance imaging

    Precise moment of loss of consciousness during anaesthesia determined through magnetic resonance imaging Awareness of this fact may provide anaesthesiologists with increased control over the procedure, allow them to carry it out more safely and allow for more accurate dosage of anaesthetics. The study, which has been published by the journal Sleep, was carried out with healthy volunteers who underwent neuroimaging tests to assess the brain's reaction during the anaesthetic procedure. Researchers have been able to determine the exact moment in which the cerebral cortex and brain stem go out of sync, namely, when loss of consciousness is achieved.

    more information

  • 8th April 2021 - Press notes

    Pompeu Fabra University and Hospital del Mar are to offer a new bachelor’s degree in Medicine tailored to current and future needs

    Pompeu Fabra University and Hospital del Mar are to offer a new bachelor’s degree in Medicine tailored to current and future needs The bachelor's degree will have a new syllabus, fully adapted to the needs of medicine today and in the future that will involve a change in the methods and approach of teaching, with a clear clinical leaning due to its integration with Hospital del Mar. One of the distinguishing features of the bachelor's degree in Medicine is its location in a unique bio-health environment, formed by the Mar University Campus, Hospital del Mar and the Barcelona Biomedical Research Park. Aspects of current medicine will be the focus, such as cancer, infectious diseases, care for the critically ill, personalized and precision medicine, systems medicine and telemedicine.

    more information

  • 9th March 2021 - Press notes

    The benefits of the Mediterranean diet pass on to the families of patients who follow it

    The benefits of the Mediterranean diet pass on to the families of patients who follow it Family members of patients who follow an intensive weight loss programme, planned within the PREDIMED study, also lose weight and improve their commitment to the Mediterranean diet. Despite not participating in the programme, these people had lost an average of almost four kilos, two years after their family member started the programme. This was particularly true in cases where they shared meals and the patient did the cooking. The same contagion effect was not observed with regard to physical activity among patients and their families. The patients also experienced improved weight loss, of almost seven kilos over the same period. The results of the study have been published in the International Journal of Obesity.

    more information

  • March 3rd, 2021 - Press notes

    Administering zinc to covid-19 patients could help towards their recovery

    Administering zinc to covid-19 patients could help towards their recovery

    Article published in Nutrients

    A study by physicians and researchers at Hospital del Mar, the Hospital del Mar Medical Research Institute and Pompeu Fabra University has shown that patients infected with SARS-CoV-2 coronavirus with lower blood zinc levels require a longer recovery time and are at higher risk of death. Mortality in this patient group  was 21% compared to 5% of those with higher levels of zinc in the blood. At the same time, the study has carried out in vitro tests which demonstrated the protective effect of this element by limiting the spread of the coronavirus in human cells. The researchers draw attention to the benefits of zinc supplementation for patients with covid-19 to speed up their recovery and to risk groups to limit the severity of its effects. The study has just been published in the journal Nutrients and was one of the highlights of the European Society of Clinical Microbiology and Infectious Diseases' conference on covid-19.

    more information

  • 12th February 2021 - Press notes

    Start of a clinical trial for the early treatment of patients with mild COVID-19 symptoms

    Start of a clinical trial for the early treatment of patients with mild COVID-19 symptoms The Hospital del Mar is the promoter of the Phase 2 study that will assess the antiviral efficacy of compound E-52862, produced by ESTEVE, in the early treatment of outpatients with mild COVID-19 symptoms.

    more information

  • 2 February, 2021 - Press notes

    Psychological distress of lockdown in pre-dementia patients prolonged during the COVID-19 de-escalation

    Psychological distress of lockdown in pre-dementia patients prolonged during the COVID-19 de-escalation The worsened mental health and mood of elderly people at risk of developing dementia, caused by the lockdown measures, was prolonged during the early weeks of de-escalation. The study, led by researchers from the Hospital del Mar Medical Research Institute and doctors from Hospital del Mar, in collaboration with the Barcelona βeta Brain Research Center, a research centre affiliated with the Pasqual Maragall Foundation, has been published in the Journal of Alzheimer's Disease. New technologies were used to monitor the participants and understand the impact of lockdown. The people who took part are part of the PIENSA study on the prevention of cognitive deterioration in stages prior to the onset of dementia.

    more information

  • 16 December 2020 - Press notes

    Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia

    Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia This work is a collaboration between Núria López-Bigas' lab at IRB Barcelona and the groups headed by Anna Bigas (Hospital del Mar Medical Research Institute) and Josep Maria Ribera (Josep Carreras Leukaemia Research Institute). The results have been published in Genome Biology.

    more information

  • December 2nd, 2020 - Press notes

    Hospital del Mar’s dual diagnosis care model is validated by experts from the UN and WHO

    Hospital del Mar’s dual diagnosis care model is validated by experts from the UN and WHO In an article published in the journal World Psychiatry, leading experts in this field recommend the approach implemented in the Barcelona centre. One of the authors of the article is Dr. Marta Torrens, Director of the Addiction Process group in the Neuropsychiatry and Addictions Institute at Hospital del Mar. Patients with a dual diagnosis are those who suffer an addiction to a substance of abuse in addition to another psychiatric disorder. The authors of the article advise authorities and organisations to adopt a multidisciplinary approach that will allow an early diagnosis of this comorbidity, and to pay particular attention to minors living with these patients.

    more information

Social commitment

  • Social commitment
  • Top 20
  • HPH Catalunya - Xarxa d'Hospitals i Centres Promotors de la Salut
Collaborating entity

© 2006 - 2024 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility